USV PRIVATE LTD

Overview

USV PRIVATE LTD is an active pharmaceutical ingredient (API) supplier with 31 active FDA Type II Drug Master Files, covering ACITRETIN USP; BLENDED METFORMIN HCL; DAPAGLIFLOZIN (DAPAGLIFLOZIN 30% W/W SOLUTION IN ISOPROPYL ALCOHOL); DOLASETRON MESYLATE USP; DONEPEZIL HYDROCHLORIDE USP MONOHYDRATE; ELAGOLIX SODIUM.

API / Drug Master Files

USV PRIVATE LTD holds 31 active (41 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• ELAGOLIX SODIUMActive2024-09-30
• EMPAGLIFLOZINActive2023-12-30
• RIVAROXABAN USP (MICRONISED)Active2023-03-31
• DAPAGLIFLOZIN (DAPAGLIFLOZIN 30% W/W SOLUTION IN ISOPROPYL ALCOHOL)Active2022-09-30
• TICAGRELORActive2021-09-24
• ETELCALCETIDE HYDROCHLORIDEActive2021-07-22
• TRIMETAZIDINE DIHYDROCHLORIDEActive2021-03-30
• SUGAMMADEX SODIUMActive2019-08-31
• ICATIBANT ACETATEActive2018-12-07
• DOLASETRON MESYLATE USPActive2018-09-28
• PALONOSETRON HYDROCHLORIDEActive2015-09-29
• REGADENOSONActive2015-06-23
• NATEGLINIDE USP [MICRONISED]Active2013-03-25
• OLOPATADINE HYDROCHLORIDE USPActive2011-01-31
• ZOLEDRONIC ACID (MONOHYDRATE)Active2010-12-24

Showing 15 of 41 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to USV PRIVATE LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.